A new internal ribosomal entry site 5' boundary is required for poliovirus translation initiation in a mouse system.
Four mutants of the virulent Mahoney strain of poliovirus were generated by introducing mutations in nucleotides (nt) 128 to 134 of the genome, a region that contains a part of the stem-loop II (SLII) structure located within the internal ribosomal entry site (IRES; nt 120 to 590) (K. Shiroki, T. Ishii, T. Aoki, Y. Ota, W.-X. Yang, T. Komatsu, Y. Ami, M. Arita, S. Abe, S. Hashizume, and A. Nomoto, J. Virol. 71:1-8, 1997). These mutants (SLII mutants) replicated well in human HeLa cells but not in mouse TgSVA cells that had been established from the kidney of a poliovirus-sensitive transgenic mouse. Their neurovirulence in mice was also greatly attenuated compared to that of the parental virus. The poor replication activity of the SLII mutants in TgSVA cells appeared to be attributable to reduced activity of the IRES. Two and three naturally occurring revertants that replicated well in TgSVA cells were isolated from mutants SLII-1 and SLII-5, respectively. The revertants recovered IRES activity in a cell-free translation system from TgSVA cells and returned to a neurovirulent phenotype like that of the Mahoney strain in mice. Two of the revertant sites that affected the phenotype were identified as being at nt 107 and within a region from nt 120 to 161. A mutation at nt 107, specifically a change from uridine to adenine, was observed in all the revertant genomes and exerted a significant effect on the revertant phenotype. Exhibition of the full revertant phenotype required mutations in both regions. These results suggested that nt 107 of poliovirus RNA is involved in structures required for the IRES activity in mouse cells.
Ishii
T
T
Department of Microbiology, Institute of Medical Science, The University of Tokyo, Japan.
Shiroki
K
K
Hong
D H
DH
Aoki
T
T
Ohta
Y
Y
Abe
S
S
Hashizume
S
S
Nomoto
A
A
D000818:Animals; D001665:Binding Sites; D002522:Chlorocebus aethiops; D016679:Genome, Viral; D006367:HeLa Cells; D006801:Humans; D051379:Mice; D008822:Mice, Transgenic; D016296:Mutagenesis; D009690:Nucleic Acid Conformation; D010641:Phenotype; D017955:Poliovirus / Q000235:genetics* / Q000472:pathogenicity; D014176:Protein Biosynthesis; D012367:RNA, Viral; D012270:Ribosomes; D014774:Virulence
D012367:RNA, Viral